Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a few words in an email boost wellness program Sign-Ups?

NCT ID NCT04047342

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 17, 2026 · Last updated Jul 17, 2026

Summary

This study tests whether the wording of emails sent to new Geisinger employees affects how many sign up for the myHealth Rewards wellness program. About 800 new hires are randomly assigned to receive either a standard welcome email or one framed around potential loss. The main outcome is enrollment within seven days.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
different email messages (welcome email vs. loss-framed email)
What this could lead to
If effective, simple email tweaks could help more employees join wellness programs, potentially improving health and reducing costs.
What could go wrong
This is a small, single-employer study focused on enrollment behavior, not health outcomes. Results may not apply to other settings or populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

824 people

The number who actually took part.

Started

Jul 2019

Finished

Jul 2020

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The population consists of new Geisinger Health Plan members who are benefits subscribers.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Any Geisinger new hire, regardless of benefits status, who started on or after July 1, 2019 and before November 30, 2019 Exclusion Criteria: * Existing Geisinger employees hired prior to July 1, 2019 * New hires who do not have an email address on file

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Health promotion are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Geisinger

    Danville, Pennsylvania, 17822, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.